179 related articles for article (PubMed ID: 28505011)
1. In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma: comparisons using thromboelastography and microscopic visualization of fibrin clot structure.
Nossair FF; Chan HHW; Gantioqui J; Atkinson HM; Berry LR; Chan AKC
Blood Coagul Fibrinolysis; 2017 Oct; 28(7):551-557. PubMed ID: 28505011
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Dabigatran Is an Effective Anticoagulant for Simulated Cardiopulmonary Bypass Using Human Blood.
Nadtochiy SM; Baldzizhar A; Stefanos T; Feng C; O'Leary KE; Jones-Smith KL; Angona RE; Eaton MP
Anesth Analg; 2021 Feb; 132(2):566-574. PubMed ID: 32833714
[TBL] [Abstract][Full Text] [Related]
3. Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
Solbeck S; Ostrowski SR; Stensballe J; Johansson PI
Int J Cardiol; 2016 Apr; 208():14-8. PubMed ID: 26826624
[TBL] [Abstract][Full Text] [Related]
4. Effects of direct oral anticoagulants on thromboelastographic parameters and fibrin clot properties in patients with venous thromboembolism.
Kopytek M; Zabczyk M; Natorska J; Malinowski KP; Undas A
J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32350148
[TBL] [Abstract][Full Text] [Related]
5. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG
Solbeck S; Jensen AS; Maschmann C; Stensballe J; Ostrowski SR; Johansson PI
Scand J Clin Lab Invest; 2018; 78(1-2):25-30. PubMed ID: 29304563
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography.
Gantioqui J; Stevic I; Atkinson H; Chan AKC
Blood Coagul Fibrinolysis; 2018 Sep; 29(6):521-527. PubMed ID: 29965810
[TBL] [Abstract][Full Text] [Related]
7. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?
Karlsson O; Jeppsson A; Hellgren M
Int J Obstet Anesth; 2014 Feb; 23(1):10-7. PubMed ID: 24342222
[TBL] [Abstract][Full Text] [Related]
8. Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro.
Xu Y; Wu W; Wang L; Chintala M; Plump AS; Ogletree ML; Chen Z
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):332-8. PubMed ID: 23348428
[TBL] [Abstract][Full Text] [Related]
9. Parameters of thromboelastography in healthy newborns.
Edwards RM; Naik-Mathuria BJ; Gay AN; Olutoye OO; Teruya J
Am J Clin Pathol; 2008 Jul; 130(1):99-102. PubMed ID: 18550478
[TBL] [Abstract][Full Text] [Related]
10. Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice.
Pretorius E; Swanepoel AC; DeVilliers S; Bester J
Thromb Res; 2017 Jun; 154():59-63. PubMed ID: 28414934
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography.
Solbeck S; Meyer MA; Johansson PI; Meyer AS; Cotton BA; Stensballe J; Schött U; Ostrowski SR
Int J Cardiol; 2014 Oct; 176(3):794-9. PubMed ID: 25156858
[TBL] [Abstract][Full Text] [Related]
12. The effect of dabigatran on the kaolin-activated whole blood thromboelastogram.
'Aho A; Byrne K
Anaesth Intensive Care; 2016 Nov; 44(6):729-733. PubMed ID: 27832560
[TBL] [Abstract][Full Text] [Related]
13. Thromboelastography on plasma reveals delayed clot formation and accelerated clot lyses in HIV-1 infected persons compared with healthy controls.
Rönsholt FF; Gerstoft J; Ullum H; Johansson PI; Katzenstein TL; Ostrowski SR
BMC Infect Dis; 2015 Sep; 15():388. PubMed ID: 26399646
[TBL] [Abstract][Full Text] [Related]
14. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy.
Karlsson O; Sporrong T; Hillarp A; Jeppsson A; Hellgren M
Anesth Analg; 2012 Oct; 115(4):890-8. PubMed ID: 22822194
[TBL] [Abstract][Full Text] [Related]
15. Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.
Taune V; Wallén H; Ågren A; Gryfelt G; Sjövik C; Wintler AM; Malmström RE; Wikman A; Skeppholm M
Thromb Res; 2017 May; 153():76-82. PubMed ID: 28347811
[TBL] [Abstract][Full Text] [Related]
16. Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization.
Zeng Z; Nallan Chakravarthula T; Alves NJ
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568238
[TBL] [Abstract][Full Text] [Related]
17. Assessing the anticoagulant effect of dabigatran in children: an in vitro study.
Dietrich K; Stang L; van Ryn J; Mitchell LG
Thromb Res; 2015 Apr; 135(4):630-5. PubMed ID: 25715905
[TBL] [Abstract][Full Text] [Related]
18. Fibrin clot formation under diverse clotting conditions: Comparing turbidimetry and thromboelastography.
Zeng Z; Fagnon M; Nallan Chakravarthula T; Alves NJ
Thromb Res; 2020 Mar; 187():48-55. PubMed ID: 31954276
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures.
Pipilis A; Makrygiannis S; Anagnostou G; Kaliampakos S; Tsakonas G; Sourlas N; Mallios P; Kostelidou T
J Thromb Thrombolysis; 2017 Jul; 44(1):9-13. PubMed ID: 28488236
[TBL] [Abstract][Full Text] [Related]
20. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Ambrose JA
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):75-9. PubMed ID: 19815816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
